Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer

Summary

This phase II trial is studying how well ixabepilone works in treating patients with metastatic, recurrent, or unresectable kidney cancer. Drugs used in chemotherapy, such as ixabepilone, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing

Timeline

Start

2005-07

Primary completion

2007-09

Completion

—

Drugs

Indications